7/14/26
A new Canadian study looked at why some people with axial spondyloarthritis (axSpA) continue to have symptoms even after trying several treatments.
Researchers studied 536 people with axSpA. About 1 in 11 people (9%) met the definition of having difficult-to-manage axSpA. Within that group, only about 1 in 4 had what researchers called treatment-refractory disease, meaning their symptoms continued because inflammation remained active despite appropriate treatment.
The study found that people with difficult-to-manage axSpA generally had:
Researchers also found that many people in this group had other health conditions that can add to pain and make symptoms harder to manage. These included:
These conditions may make someone feel worse even when inflammation from axSpA is under good control.
People whose disease was truly treatment-refractory were different. They were less likely to have fibromyalgia or degenerative spine disease. Instead, their symptoms appeared to be driven mainly by ongoing inflammation that was not responding well to available treatments.
The researchers say these findings show that persistent symptoms in axSpA do not always have the same cause. For some people, controlling inflammation may not be enough. They may also need evaluation and treatment for other conditions that contribute to pain and reduced function.
The authors note that this was a single study conducted at one center and that more research is needed before these findings change clinical practice.
References:
Input your search keywords and press Enter.
